183 related articles for article (PubMed ID: 22514030)
1. A transformation class for spatio-temporal survival data with a cure fraction.
Hurtado Rúa SM; Dey DK
Stat Methods Med Res; 2016 Feb; 25(1):167-87. PubMed ID: 22514030
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian piecewise survival cure rate model for spatially clustered data.
Hurtado Rúa SM; Dey DK
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():149-159. PubMed ID: 31128624
[TBL] [Abstract][Full Text] [Related]
3. A general class of Bayesian survival models with zero and nonzero cure fractions.
Yin G; Ibrahim JG
Biometrics; 2005 Jun; 61(2):403-12. PubMed ID: 16011686
[TBL] [Abstract][Full Text] [Related]
4. Laplacian-P-splines for Bayesian inference in the mixture cure model.
Gressani O; Faes C; Hens N
Stat Med; 2022 Jun; 41(14):2602-2626. PubMed ID: 35699121
[TBL] [Abstract][Full Text] [Related]
5. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
Pennell ML; Whitmore GA; Ting Lee ML
Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
[TBL] [Abstract][Full Text] [Related]
6. Spatial extended hazard model with application to prostate cancer survival.
Li L; Hanson T; Zhang J
Biometrics; 2015 Jun; 71(2):313-22. PubMed ID: 25521422
[TBL] [Abstract][Full Text] [Related]
7. A Weibull regression model with gamma frailties for multivariate survival data.
Sahu SK; Dey DK; Aslanidou H; Sinha D
Lifetime Data Anal; 1997; 3(2):123-37. PubMed ID: 9384618
[TBL] [Abstract][Full Text] [Related]
8. Bayesian transformation cure frailty models with multivariate failure time data.
Yin G
Stat Med; 2008 Dec; 27(28):5929-40. PubMed ID: 18618427
[TBL] [Abstract][Full Text] [Related]
9. Bayesian analysis of proportional hazards models built from monotone functions.
Gelfand AE; Mallick BK
Biometrics; 1995 Sep; 51(3):843-52. PubMed ID: 7548703
[TBL] [Abstract][Full Text] [Related]
10. Bayesian dynamic regression models for interval censored survival data with application to children dental health.
Wang X; Chen MH; Yan J
Lifetime Data Anal; 2013 Jul; 19(3):297-316. PubMed ID: 23389549
[TBL] [Abstract][Full Text] [Related]
11. Bayesian inference for Cox proportional hazard models with partial likelihoods, nonlinear covariate effects and correlated observations.
Zhang Z; Stringer A; Brown P; Stafford J
Stat Methods Med Res; 2023 Jan; 32(1):165-180. PubMed ID: 36317395
[TBL] [Abstract][Full Text] [Related]
12. Bayesian accelerated failure time model for space-time dependency in a geographically augmented survival model.
Onicescu G; Lawson A; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Stat Methods Med Res; 2017 Oct; 26(5):2244-2256. PubMed ID: 26220537
[TBL] [Abstract][Full Text] [Related]
13. Zero-inflated spatio-temporal models for disease mapping.
Torabi M
Biom J; 2017 May; 59(3):430-444. PubMed ID: 28187237
[TBL] [Abstract][Full Text] [Related]
14. Bayesian cure rate models induced by frailty in survival analysis.
de Souza D; Cancho VG; Rodrigues J; Balakrishnan N
Stat Methods Med Res; 2017 Oct; 26(5):2011-2028. PubMed ID: 28656796
[TBL] [Abstract][Full Text] [Related]
15. Joint longitudinal and survival-cure models in tumour xenograft experiments.
Pan J; Bao Y; Dai H; Fang HB
Stat Med; 2014 Aug; 33(18):3229-40. PubMed ID: 24753021
[TBL] [Abstract][Full Text] [Related]
16. Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.
Gupta C; Cobre J; Polpo A; Sinha D
Biom J; 2016 Sep; 58(5):1164-77. PubMed ID: 27162061
[TBL] [Abstract][Full Text] [Related]
17. Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data.
Wang M; Li Z; Lu J; Zhang L; Li Y; Zhang L
BMC Med Res Methodol; 2024 Apr; 24(1):86. PubMed ID: 38589783
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cure rate survival data under proportional odds model.
Gu Y; Sinha D; Banerjee S
Lifetime Data Anal; 2011 Jan; 17(1):123-34. PubMed ID: 20521166
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian survival treed hazards model using latent Gaussian processes.
Payne RD; Guha N; Mallick BK
Biometrics; 2024 Jan; 80(1):. PubMed ID: 38364805
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
Leão J; Leiva V; Saulo H; Tomazella V
Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
